Halscion, Inc.

About:

Halscion develops hydrogel scaffolds to improve wound and scar healing following the suturing of a wound.

Top Investors: Versant Ventures, SV Health Investors, Accuitive Medical Ventures

Description:

HALSCION, INC. develops devices to improve wound healing and the resulting scar outcomes. The company offers single-use hydrogel scaffolds that are applied during surgery to the dermal-subdermal interface of wound by injection. Its products include biocompatible materials that provide a structural framework upon, which wound healing cells, such as fibroblasts migrate into the wound and organize. The company was incorporated in 2005 and is based in Suwanee, Georgia.

Total Funding Amount:

$13.8M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Duluth, Georgia, United States

Founded Date:

2005-01-01

Contact Email:

info(AT)halscion.net

Founders:

Charles E. Larsen, Charles Larsen

Number of Employees:

1-10

Last Funding Date:

2016-07-23

IPO Status:

Private

Industries: